Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $113.3, a high estimate of $130.00, and a low estimate of $95.00. This current ...

The "Bioprocess Filtration: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for bioprocess filtration is estimated to grow from $8.4 billion in 2025 to ...

The "Biological Therapies for Cancer: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.

Gender equality slipped back last year in the executive suites of Germany's 90 largest companies listed on the Frankfurt ...

The US FDA approved 46 new drugs in 2025, despite a tumultuous year at the regulatory agency.

Although active cancer is recognised as a risk factor for increased bleeding, the specific bleeding risks associated with ...

Merck stock earns a cautious "Buy." Learn more about its valuation, Keytruda risks, pipeline potential, and long-term growth.

U.S. President Donald Trump announced Friday, Dec. 19 that nine drugmakers have agreed to lower the cost of their ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

Merck (MRK) stock achieved a 5-day winning streak, with total gains during this time reaching 6.9%. The company’s market ...

President Donald Trump announced Friday that nine additional pharmaceutical companies joined its most-favored-nation pricing initiative.

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...